4P
4PC.F Perimeter Medical Imaging AI Inc
- Market cap
- EUR 12.0M
- P/E
- -
- P/B
- 2.94x
- ROE
- -312.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is 4PC.F undervalued?
Graham numberThe Graham number of Perimeter Medical Imaging AI Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Perimeter Medical Imaging AI Inc fundamental analysis
No fundamental analysis for Perimeter Medical Imaging AI Inc yet.
Perimeter Medical Imaging AI Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Perimeter Medical Imaging AI Inc
Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging solutions to address unmet medical needs. The company offers the Perimeter S-Series optical coherence tomography (OCT) imaging system, which delivers cross-sectional, real-time margin visualization of excised tissue specimens in the operating room. It also provides Claire OCT, with ImgAssist artificial intelligence for patients undergoing breast conservation surgery. In addition, the …
Full company profilePerimeter Medical Imaging AI Inc financial statements
Perimeter Medical Imaging AI Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 119M | 131M | 124M | 0.00 | 0.00 | 9.00K | 133K | 404K | 846K | 2.30M |
| Gross Profit | 45.8M | 49.2M | 1.25M | - | 0.00 | 4.00K | -3.33K | 206K | 535K | 1.47M |
| Operating Income | 12.5M | 14.8M | -42.5M | -8.56M | -10.1M | -12.8M | -16.1M | -16.3M | -18.7M | -12.9M |
| EBITDA | - | - | - | -10.1M | -7.74M | -16.4M | -9.00M | -13.3M | -12.6M | -12.1M |
| Net Income | 7.22M | 8.70M | -79.7M | -10.3M | -7.89M | -13.3M | -9.91M | -14.0M | -13.4M | -12.9M |
| EPS | - | - | - | - | -0.20 | -0.29 | -0.15 | -0.22 | -0.14 | -0.10 |
| Balance Sheet | ||||||||||
| Total Assets | 362M | 390M | 312M | 2.55M | 13.2M | 7.88M | 34.6M | 20.5M | 14.3M | 6.73M |
| Total Liabilities | 154M | 163M | 153M | 19.0M | 2.40M | 2.02M | 8.49M | 5.48M | 3.87M | 2.60M |
| Shareholders' Equity | 208M | 226M | 159M | -16.5M | 10.8M | 5.86M | 26.1M | 15.1M | 10.5M | 4.13M |
| Cash & Short-term Investments | 32.7M | 24.0M | 25.7M | 1.21M | 10.0M | 3.72M | 28.4M | 14.0M | 6.18M | 2.47M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 10.3M | 2.84M | -4.09M | -5.79M | -8.26M | -13.9M | -11.9M | -14.7M | -14.7M | -9.29M |
| Capital Expenditure | 44.4M | 23.1M | 53.9K | 46.9K | 0.00 | 2.12M | 1.99M | 475K | 2.18M | 128K |
| Free Cash Flow | - | - | - | -5.83M | -8.26M | -16.0M | -13.9M | -15.2M | -16.9M | -9.42M |
| Ratios | ||||||||||
| ROE | 3.5% | 3.8% | -50.0% | - | -73.3% | -226.4% | -37.9% | -93.2% | -128.1% | -312.9% |
| ROA | 2.0% | 2.2% | -25.5% | -405.2% | -59.9% | -168.3% | -28.6% | -68.3% | -93.5% | -192.0% |
| Net Profit Margin | 6.1% | 6.6% | -64.3% | - | - | -147,285.3% | -7,461.3% | -3,478.3% | -1,582.8% | -560.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Perimeter Medical Imaging AI Inc dividends
Perimeter Medical Imaging AI Inc has not paid dividends in the last 10 fiscal years.
Who owns Perimeter Medical Imaging AI Inc
- Insiders 18.71%
- Institutions 19.18%
- Public & others 62.11%
- Shares outstanding 153M
- Free float 95.6M
Perimeter Medical Imaging AI Inc company profile
- Company name
- Perimeter Medical Imaging AI Inc
- Ticker
- 4PC.F
- ISIN
- CA71385D1078
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 36
- Fiscal year end
- June
- Address
- 555 Richmond Street West, Toronto, ON, Canada, M5V 3B1
- Phone
- 214-845-5154
- Website
- perimetermed.com
About Perimeter Medical Imaging AI Inc
Perimeter Medical Imaging AI, Inc., a medical technology company, provides advanced imaging solutions to address unmet medical needs. The company offers the Perimeter S-Series optical coherence tomography (OCT) imaging system, which delivers cross-sectional, real-time margin visualization of excised tissue specimens in the operating room. It also provides Claire OCT, with ImgAssist artificial intelligence for patients undergoing breast conservation surgery. In addition, the company provides a proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. is headquartered in Toronto, Canada.
Perimeter Medical Imaging AI Inc management
7- Mr. Adrian MendesCEO & Director
- Ms. Sara BrienChief Financial Officer
- Mr. Andrew BerkeleyCo-Founder & Chief Innovation Officer
- Ms. Jodi Regts B.A., M.B.A.Corporate Communications & Investor Relations Officer
- Ms. Abbey GoodmanVice President of Sales · born 1983
- Dr. Ted James F.A.C.S., M.D., M.S.Chief Medical Officer & Member of Advisory Board
- Stephen KilmerInvestor Relations Officer